Bank of America has provided exclusive financial advisory services for Boston Scientific’s acquisition of Silk Road Medical, valued at $1.26 billion.
Silk Road Medical, known for its innovative devices aimed at reducing stroke risks, is set to enhance Boston Scientific’s cardiology portfolio significantly. Cat Jennings, President of Boston Scientific, emphasized
You must be logged in to post a comment.